Rapid ASPECTS vs ContaCT

Direct competitors — feature-level head-to-head below. Comparability 80/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by RapidAI
VS
by Viz.AI

AI Verdict

Rapid ASPECTS specializes in automated ASPECTS scoring from non-contrast CT scans to quantify early ischemic changes and aid in thrombectomy eligibility for stroke patients. ContaCT, part of the Viz.AI platform, offers a broader AI-powered care coordination solution that includes stroke detection (LVO, ICH) and streamlines clinical workflows for multiple conditions. While Rapid ASPECTS provides a highly focused diagnostic score, ContaCT offers a more comprehensive platform for disease detection and communication across the care continuum, making them direct competitors in the acute stroke management space.

Choose Rapid ASPECTS if…

Choose Rapid ASPECTS if your primary need is a highly specialized, automated solution for quickly and objectively assessing early ischemic changes in stroke patients using non-contrast CT scans. This tool is ideal for facilities focused on standardizing ASPECTS scoring to precisely determine thrombectomy eligibility with improved diagnostic accuracy and reduced variability.

View Rapid ASPECTS →

Choose ContaCT if…

Choose ContaCT if your organization requires a broad, AI-powered care coordination platform designed to accelerate detection and streamline workflows across multiple acute conditions, not just stroke. This solution is best suited for health systems aiming to enhance real-time communication, facilitate rapid specialist consultation via mobile access, and integrate AI insights seamlessly into existing PACS and EHR systems for comprehensive patient management.

View ContaCT →

When choosing between Rapid ASPECTS and ContaCT, physicians should consider their primary need: automated scoring for stroke assessment or comprehensive care coordination. Rapid ASPECTS, from RapidAI, excels at providing an automated, standardized ASPECTS score from non-contrast CT scans in under two minutes. This tool is specifically designed to quantify early ischemic changes, visualize regions of asymmetry, and improve diagnostic accuracy, making it ideal for facilities focused on rapid, consistent stroke assessment to aid in thrombectomy eligibility decisions.

In contrast, Viz.ai’s ContaCT offers a broader AI-powered care coordination platform. While it includes AI-powered disease detection for stroke (LVO, ICH), its key practical difference lies in its real-time alerts, secure group communication, and integration with existing hospital IT infrastructure (PACS, EHR). This makes ContaCT more suitable for institutions aiming to streamline clinical workflows, accelerate disease detection across multiple conditions, and enhance communication among specialists. Physicians prioritizing a dedicated, rapid, and objective stroke scoring tool should lean towards Rapid ASPECTS, while those seeking an integrated platform for disease detection and care team communication across various conditions may find ContaCT more beneficial.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Rapid ASPECTS ContaCT
Pricing Annual subscription model; pricing varies by region, hospital type, modules, and imaging modalities. starts at approximately $12,000 for a single module in the united states. Subscription-based
Deployment Software as a Medical Device (SaMD), delivered via PACS, email, and mobile/web applications (cloud-based). Cloud-based, integrates with existing hospital IT infrastructure (PACS, EHR).
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ContaCT

While both tools offer cloud-based access via mobile and web applications, Tool B (ContaCT) provides a more comprehensive suite of features that enhance usability for the entire care team. Its mobile application includes secure group communication, a high-fidelity 3D image viewer, and automated chart summarization, streamlining clinical workflows beyond just delivering results.

Clinical Value

ContaCT

Rapid ASPECTS offers a specific, quantifiable improvement in diagnostic accuracy for ASPECTS scoring in stroke patients and is the first neuroimaging solution with CADx FDA clearance. However, ContaCT provides broader AI-powered disease detection across multiple pathologies (LVO, ICH, HCM, PE, Aneurysm) and has demonstrated significant workflow improvements, such as an 11-minute reduction in door-to-groin time for LVO cases. Its widespread adoption in over 1,700 hospitals globally and extensive clinical validation across various conditions suggest a more comprehensive and impactful clinical value proposition.

Pricing & Value

Rapid ASPECTS

Tool A (Rapid ASPECTS) offers greater transparency by providing a starting price point of approximately $12,000 for a single module in the United States. In contrast, Tool B (ContaCT) states that its pricing 'varies significantly' and is 'often tiered,' which offers less clarity for potential customers trying to understand initial costs.

Enterprise Readiness

ContaCT

Both tools demonstrate strong foundational enterprise readiness with HIPAA compliance, BAA, and FDA clearance. However, Tool B (ContaCT) explicitly mentions integration with existing hospital IT infrastructure, including PACS and EHR systems, and has a proven track record of deployment in over 1,700 hospitals globally, indicating a higher degree of established scalability and integration capabilities.

Innovation

ContaCT

While Rapid ASPECTS offers innovative automated ASPECTS scoring for stroke, ContaCT presents a broader and more integrated innovation as a 'pioneering AI-powered care coordination platform.' Its capabilities extend to multi-disease detection, real-time AI-powered alerts, secure group communication, and automated chart summarization, representing a more comprehensive and systemic application of AI to optimize clinical workflows.

Support & Docs

Tie

Both RapidAI and Viz.ai offer robust 24/7/365 customer support via phone and email, which is crucial for healthcare operations. RapidAI provides a 'Resources' section with 'Expert guides, videos, and learning materials' and a 'Help Center', while Viz.ai offers 'User Guides,' 'Viz Academy,' and a comprehensive 'Resources' section with clinical validation, webinars, and white papers. The level of documentation and support appears comparable and comprehensive for both solutions.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Rapid ASPECTS ContaCT
Product Name Rapid ASPECTS ContaCT
Company RapidAI Viz.AI
Primary Use Case Automated, standardized ASPECTS score from non-contrast CT scans to quantify early ischemic changes and aid in determining thrombectomy eligibility for stroke patients. AI-powered care coordination platform that accelerates disease detection and streamlines clinical workflows, helping ensure patients receive timely treatment.
Automated Detection/Scoring Automated ASPECTS score generation for non-contrast CT scans. AI-powered disease detection (LVO, ICH, HCM, PE, Aneurysm).
Workflow/Communication Features Fast results delivery (under 2 minutes). Real-time AI-powered alerts and notifications; Mobile application for specialists to view images and communicate; Secure, HIPAA-compliant group communication messaging; Automated chart summarization; Guideline-based recommendations.
Image Viewing Capabilities Visualization of regions of asymmetry and ischemic change; Creates high-quality images from non-contrast CT studies. Mobile application for specialists to view images; High-fidelity 3D web and mobile image viewer.

Videos

Demos, reviews, and walkthroughs featuring Rapid ASPECTS and ContaCT.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Rapid ASPECTS specifically focuses on providing an automated, standardized ASPECTS score from non-contrast CT scans to quantify early ischemic changes and aid in determining thrombectomy eligibility for stroke patients. ContaCT, part of the Viz.ai platform, offers broader AI-powered disease detection for multiple conditions, including Large Vessel Occlusion (LVO), Intracerebral Hemorrhage (ICH), Hypertrophic Cardiomyopathy (HCM), Pulmonary Embolism (PE), and Aneurysm, with its initial application being for stroke.
Rapid ASPECTS generates an automated ASPECTS score to help quantify ischemic changes and assist in determining thrombectomy eligibility, with results delivered quickly via PACS, email, and mobile/web applications. ContaCT, as a care coordination platform, provides real-time AI-powered alerts and notifications, a mobile application for specialists to view images and communicate securely, and integrates with PACS and EHR systems to streamline workflows for timely treatment.
Rapid ASPECTS delivers its automated scores and visualizations via PACS, email, and mobile/web applications, aiming for fast results delivery (under 2 minutes). ContaCT emphasizes care coordination through real-time AI alerts, a mobile application for specialists to view images and engage in secure, HIPAA-compliant group communication messaging, and integrates with existing hospital IT infrastructure like PACS and EHR systems.
Rapid ASPECTS claims to improve clinician diagnostic accuracy by 10% and increase reader reliability while reducing intra-reader variability, especially among non-expert readers. ContaCT aims to accelerate disease detection and streamline clinical workflows to ensure patients receive timely treatment, with reported increases in thrombectomy rates at large stroke hubs.
Rapid ASPECTS utilizes clinically validated machine-learning algorithms to automatically generate standardized ASPECTS scores from non-contrast CT scans, identifying regions of asymmetry and ischemic change. ContaCT employs AI for disease detection across various conditions, including LVO and ICH, providing real-time alerts and guideline-based recommendations to assist in clinical decision support.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.